Is ImmuCell Corporation overvalued?

ImmuCell Corporation (ICCC) — key valuation metrics and fundamentals.

No verdict

Price

$10.05

Fair value

—

Current P/E

—

Normal P/E

21.7

Market cap

$90.9M

Dividend yield

0.0%

Return on equity

-1.9%

Sector

Healthcare

Fair value compares ICCC's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks